FIELD: chemistry.
SUBSTANCE: description is given of compounds with general formula (I) 
in which R1 represents an atom of hydrogen or a C1-C4alkenyl group; R2 and R3, which can be the same or different, represent a C1-C4alkenyl group, or R2 and R3 together with a carbon atom, to which they are bonded, form a cyclic aliphatic group, containing 3-7 atoms of carbon; R4 and R5, which can be the same or different, represent a hydrogen atom or a C1-C4alkenyl group; X is chosen from a group, containing a halogen; B contains at least, one amino group with basic characteristics or a tetraalkylammonium group and can be chosen from a group, containing: NR6Y and from residue: 
Non-peptide compounds with formula (I) have activity of specific antagonists to B2-receptors bradykinine. Description is also given of intermediate compounds, pharmaceutical compositions.
EFFECT: possibility of using the compounds for obtaining pharmaceutical compositions for treating damages, when there is need for using a bradykinine antagonist.
11 cl, 115 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 2-IMINOPYRROLIDINE | 2002 |
|
RU2270192C2 |
| PYRAZOLE DERIVATIVES APPLIED AS PROTEIN KINASE INHIBITORS | 2013 |
|
RU2623221C2 |
| DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
| DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
| DIAMINOTRIAZOLES, SUITABLE AS INHIBITORS OF PROTEIN KINASES | 2003 |
|
RU2350606C2 |
| NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (1) | 2005 |
|
RU2330021C2 |
| METHODS FOR TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES WITH USE OF 2,4-PYRIMIDINEDIAMINE | 2013 |
|
RU2659777C2 |
| BENZOTRIAZEPINES AS GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | 2002 |
|
RU2304438C2 |
| 7-SUBSTITUTED INDOLE Mcl-1 INHIBITORS | 2008 |
|
RU2473542C2 |
| PYRIDAZINONE DERIVATIVES AS PARP INHIBITORS | 2008 |
|
RU2490265C2 |
